Charles Schwab
QTTB icon

Charles Schwab’s Q32 Bio QTTB Stock Holding History

Charles Schwab’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,190
Closed -$23.4K – 3598
2025
Q1 		$23.4K Sell
14,190
-1,226
-8% -$3.3K ﹤0.01% 3453
2024
Q4 		$53K Buy
15,416
+6
+0% +$189 ﹤0.01% 3436
2024
Q3 		$688K Hold
15,410
– – ﹤0.01% 3043
2024
Q2 		$277K Buy
+15,410
New +$369K ﹤0.01% 3385
2024
Q1 		– Sell
-1,221
Closed -$13.4K – 3529
2023
Q4 		$13.4K Hold
1,221
– – ﹤0.01% 3510
2023
Q3 		$25.7K Hold
1,221
– – ﹤0.01% 3485
2023
Q2 		$19.4K Hold
1,221
– – ﹤0.01% 3564
2023
Q1 		$22.6K Hold
1,221
– – ﹤0.01% 3493
2022
Q4 		$27.7K Hold
1,221
– – ﹤0.01% 3465
2022
Q3 		$36K Buy
+1,221
New +$49.8K ﹤0.01% 3405
2022
Q2 		– Sell
-6,217
Closed -$341K – 3658
2022
Q1 		$341K Buy
6,217
+140
+2% +$8.7K ﹤0.01% 3187
2021
Q4 		$399K Hold
6,077
– – ﹤0.01% 3222
2021
Q3 		$861K Sell
6,077
-10,720
-64% -$1.37M ﹤0.01% 2925
2021
Q2 		$2.2M Buy
16,797
+4,987
+42% +$622K ﹤0.01% 2682
2021
Q1 		$2M Sell
11,810
-596
-5% -$126K ﹤0.01% 2663
2020
Q4 		$2.52M Buy
12,406
+97
+0.8% +$18.7K ﹤0.01% 2534
2020
Q3 		$2.37M Buy
12,309
+1,915
+18% +$429K ﹤0.01% 2435
2020
Q2 		$2.84M Buy
10,394
+1,826
+21% +$487K ﹤0.01% 2293
2020
Q1 		$2.4M Buy
8,568
+151
+2% +$46.2K ﹤0.01% 2200
2019
Q4 		$3.14M Buy
8,417
+151
+2% +$43.2K ﹤0.01% 2257
2019
Q3 		$2.69M Buy
8,266
+173
+2% +$58.8K ﹤0.01% 2281
2019
Q2 		$2.85M Buy
8,093
+4,258
+111% +$1.67M ﹤0.01% 2235
2019
Q1 		$1.91M Buy
3,835
+130
+4% +$58.1K ﹤0.01% 2372
2018
Q4 		$1.49M Buy
3,705
+679
+22% +$257K ﹤0.01% 2420
2018
Q3 		$1.25M Buy
3,026
+308
+11% +$105K ﹤0.01% 2554
2018
Q2 		$998K Buy
+2,718
New +$973K ﹤0.01% 2587

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab's QTTB Position: Q2 2025 in Review

Charles Schwab sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 14,190 shares — an estimated $23.4K sold.

Charles Schwab first reported a position in QTTB in Q2 2018 and held it in 26 quarters. The position peaked at $3.14M in Q4 2019. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Charles Schwab reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Charles Schwab sold 14,190 Q32 Bio shares in Q2 2025, an estimated $23.4K.
  • Charles Schwab first reported a position in Q32 Bio in Q2 2018 and held it in 26 quarters.
  • Charles Schwab's Q32 Bio position peaked at $3.14M in Q4 2019.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.